EQUITY Equity (Tables)
|
9 Months Ended |
Sep. 30, 2022 |
|---|
| Equity [Abstract] |
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the nine months ended September 30, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flow Hedge |
|
Foreign Currency Items |
|
Total |
|
(in thousands) |
| Balance at December 31, 2021 |
$ |
(8,558) |
|
|
$ |
(139,406) |
|
|
$ |
(147,964) |
|
Other comprehensive income before reclassifications |
50,178 |
|
|
(58,731) |
|
|
(8,553) |
|
| Amount reclassified from AOCI |
2,634 |
|
|
— |
|
|
2,634 |
|
| Net other comprehensive income |
52,812 |
|
|
(58,731) |
|
|
(5,919) |
|
| Balance at September 30, 2022 |
$ |
44,254 |
|
|
$ |
(198,137) |
|
|
$ |
(153,883) |
|
|
| Schedule of Weighted Average Number of Shares |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
| Weighted average common shares—basic |
225,761,777 |
|
|
216,888,355 |
|
|
224,123,130 |
|
|
215,716,239 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Stock options and restricted stock |
6,060,991 |
|
|
6,912,045 |
|
|
7,409,515 |
|
|
— |
|
| Convertible senior notes |
11,864,035 |
|
|
— |
|
|
8,085,275 |
|
|
— |
|
| Weighted average common shares—diluted |
243,686,803 |
|
|
223,800,400 |
|
|
239,617,920 |
|
|
215,716,239 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income (Loss) Per Common Share |
The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
| Options to purchase shares of common stock |
3,750 |
|
|
3,750 |
|
|
3,750 |
|
|
7,727,064 |
|
| Restricted stock and deferred stock—unvested |
1,340,319 |
|
|
91,275 |
|
|
1,260,701 |
|
|
3,207,115 |
|
|
|
|
|
|
|
|
|
| Conversion shares related to the convertible senior notes |
— |
|
|
11,864,035 |
|
|
3,778,760 |
|
|
11,864,035 |
|
| Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
1,344,069 |
|
|
11,959,060 |
|
|
5,043,211 |
|
|
22,798,214 |
|
|